Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes (Q40073861)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

blood–brain barrier

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Tetsuya Terasaki

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1

object named as

Shingo Ito

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

4

object named as

Yasuko Nezu

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

3

object named as

Junichi Kamiie

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

0 references

publication date

1 October 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

2482-2490

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

The low-density lipoprotein receptor-related protein is a pro-survival receptor in Schwann cells: possible implications in peripheral nerve injury.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Blood-brain barrier transport of a novel micro 1-specific opioid peptide, H-Tyr-D-Arg-Phe-beta-Ala-OH (TAPA).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Soluble Amyloid Aβ-(1–40) Exists as a Stable Dimer at Low Concentrations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Functional characterization of the brain-to-blood efflux clearance of human amyloid-beta peptide (1-40) across the rat blood-brain barrier

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Pharmacokinetic analysis of the blood-brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP,PS1) and its implications for amyloid plaque formation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein is increased in reactive and neoplastic glial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Alpha2-macroglobulin enhances the clearance of endogenous soluble beta-amyloid peptide via low-density lipoprotein receptor-related protein in cortical neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Brain insulin impairs amyloid-beta(1-40) clearance from the brain.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

A novel role for receptor-associated protein in somatostatin modulation: implications for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

39-kD protein inhibits tissue-type plasminogen activator clearance in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2007.04938.X

21 January 2018

Identifiers

10.1111/J.1471-4159.2007.04938.X

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40073861&oldid=1883662890"